Ardent Health, Inc. (ARDT) EBITDA
- 2026-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $42.99M.
- 2025-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $36.20M.
- 2024-03-31: Basis Reported; EBITDA (m); Operating income (m); Depreciation and amortization $35.35M.
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Reported | (m) | (m) | $42.99M | (m) | (m) | (m) | -$60.22M | (m) | (m) | (m) | $16.10M |
| 2025-03-31 | Reported | (m) | (m) | $36.20M | (m) | (m) | (m) | -$24.79M | (m) | (m) | (m) | $15.23M |
| 2024-03-31 | Reported | (m) | (m) | $35.35M | (m) | (m) | (m) | -$14.69M | (m) | (m) | (m) | $10.71M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | (m) | $155.70M | (m) | (m) | (m) | $470.51M | (m) | (m) | (m) | $56.22M |
| 2024-12-31 | Reported | (m) | (m) | $146.29M | (m) | (m) | (m) | $315.03M | (m) | (m) | (m) | $63.35M |
| 2023-12-31 | Reported | (m) | (m) | $140.84M | (m) | (m) | (m) | $221.70M | (m) | (m) | (m) | $22.64M |
| 2022-12-31 | Reported | (m) | (m) | $138.17M | (m) | (m) | (m) | -$38.36M | (m) | (m) | (m) | $46.11M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |